Return all Bliss GVS Pharma drugs-FDA cautions
The Food and Drugs Authority (FDA) on Monday cautioned hospitals, pharmacies, licensed chemical shops or distributor of pharmaceutical products to return any medicines from Bliss GVS Pharma Limited in stock to their suppliers with immediate effect.
This has been necessary following the blacklisting of Bliss GVS Pharma Limited, partner of Tobinco Pharmaceuticals, after the FDA detected over 100 medicines imported by Tobinco from Bliss GVS to be fake and unregistered on the Ghanaian market.
A statement issued and signed by the Chief Executive Officer of FDA, copied to the Ghana News Agency, said dossiers and documentation submitted to the FDA by Bliss GVS Pharma Limited, partner of Tobinco Pharmaceuticals have been found to be forged.
‘This technically, makes the medicines fake. The FDA will therefore not proceed to analyse such medicinal products’, it added.
The statement noted that Bliss GVS Pharma has to date failed to submit all the necessary documentation required for re-registration of the few medicinal products that he applied for re-registration.
It explained that the Director of Bliss GVS Pharma admitted before officials of FDA that Gsunate Plus Suppository was a fake anti-malarial and was not used in India to treat malaria in children.
‘Since they submitted forged dossier/documentation and also put fake medicines on the Ghanaian market, the FDA is cautioning the general public against patronising medicinal products manufactured by Bliss GVS Pharma Ltd, India’, it said.
‘All hospitals, pharmacies, distributors and licensed chemical shops who have in stock medicines from Bliss GVS Pharma should return them to the suppliers.
‘Anybody found dealing in Bliss GVS products will be sanctioned. The World Health Organization has been accordingly informed of the ban placed on Bliss GVS Pharma Ltd’.
Leave a comment. 0 comment so far.